ReviewFrontiers in immunology2026
Innate immune circuits in acute lung injury: macrophage plasticity, ILC crosstalk, and tissue repair failure.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are traditionally understood as hyperinflammatory syndromes characterized by cytokine excess, neutrophil infiltration, and disruption of the alveolar-capillary barrier. However, this framework does not fully explain why some injured lungs undergo effective resolution whereas others progress toward persistent inflammation, defective epithelial regeneration, and long-term pulmonary dysfunction. Increasing evidence suggests that ALI is better conceptualized as a disorder of dysregulated tissue-centered innate immune circuits rather than a simple consequence of uncontrolled inflammation. Among the key cellular regulators of these circuits, macrophages and innate lymphoid cells (ILCs), especially ILC2s, play central and complementary roles. Macrophages function as early sentinels, inflammatory amplifiers, efferocytic cleaners, and reparative coordinators, with their impact determined by lineage origin, temporal state transitions, and niche-dependent plasticity. ILCs, in parallel, translate epithelial alarm signals into tissue-adaptive responses and contribute to barrier protection, homeostatic restoration, and modulation of macrophage function. Importantly, macrophages, ILCs, and epithelial cells form an interdependent communication network that governs the balance between inflammatory escalation and successful repair. When this network becomes disrupted, the injured lung shifts from coordinated recovery to failed repair. In this review, we discuss macrophage heterogeneity and plasticity in ALI, epithelial-macrophage and macrophage-ILC crosstalk, mechanisms of inflammatory resolution and repair failure, and emerging therapeutic opportunities aimed at restoring innate immune circuit competence in the injured lung.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.